Free Trial

Oxford Nanopore Technologies (LON:ONT) Stock Price Down 10.2% - Time to Sell?

Oxford Nanopore Technologies logo with Medical background

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) dropped 10.2% on Monday . The company traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61). Approximately 3,354,197 shares were traded during trading, an increase of 54% from the average daily volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analyst Ratings Changes

Several equities research analysts recently weighed in on ONT shares. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Berenberg Bank reiterated a "buy" rating and issued a GBX 282 ($3.54) price objective on shares of Oxford Nanopore Technologies in a report on Tuesday, September 3rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 190 ($2.38) price target on shares of Oxford Nanopore Technologies in a research note on Wednesday, September 4th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of GBX 235.50 ($2.95).

Get Our Latest Stock Analysis on Oxford Nanopore Technologies

Oxford Nanopore Technologies Stock Performance

The company's 50-day simple moving average is GBX 142.50 and its 200-day simple moving average is GBX 129.78. The stock has a market cap of £1.21 billion, a price-to-earnings ratio of -642.50 and a beta of 0.80. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07.

Insider Transactions at Oxford Nanopore Technologies

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the company's stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total value of £2,830,870.82 ($3,548,791.30). Insiders have purchased 310 shares of company stock valued at $45,010 over the last three months. Company insiders own 32.62% of the company's stock.

Oxford Nanopore Technologies Company Profile

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

See Also

Should You Invest $1,000 in Oxford Nanopore Technologies Right Now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines